About the Webinar
After 30 years without any advancement in scabies therapy, novel NatrobaTM is the first targeted topical agent to demonstrate what the FDA now defines as a “complete cure”.1
In this webinar, you’ll learn about the new FDA guidelines for efficacy and how the patented NatrobaTM (spinosad) formulation delivers unparalleled efficacy and safety in adult and pediatric patients based on two Phase III clinical trials.1-3
You’ll also have an opportunity to discuss this important new treatment option live with the clinical expert.
About the Speaker
Dr. Ahmad Amin is an Assistant Professor of Dermatology at Northwestern University Feinberg School of Medicine and physician at Northwestern Medicine Dermatology in Chicago, IL.
Reserve Your Place
Thanks for your interest!
Keep an eye on your inbox. We’ll send a reminder email the week of the webinar. In the meantime, learn more about Natroba™.